Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhen Quan
Observed names:
Quan Zhen,
Quan, Zhen,
ZHEN QUAN
Institution:
The Affiliated Yongchuan Hospital of Chongqing Medical University
Observed institutions:
Jiangnan University,
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Southwest Hospital,
Chongqing Medical University
ORCID:
0000-0001-7782-3193
Observed ORCID:
0000-0001-7782-3193
OpenAlex ID:
A5012243724
Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway
2017
·
Yang Xia
, Qiongfang Zhang
, et al.
·
Oncotarget
·
92
Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM
2020
·
Ting Li
, Nanjing Liu
, et al.
·
British Journal of Cancer
·
53
PDF
Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b
2017
·
Zhen Quan
, Yunfeng He
, et al.
·
Cellular Signalling
·
40
Exosome-derived microRNA-29c Induces Apoptosis of BIU-87 Cells by Down Regulating BCL-2 and MCL-1
2014
·
Xiang-Dong Xu
, Xiao-Hou Wu
, et al.
·
Asian Pacific Journal of Cancer Prevention
·
37
Simvastatin delays castration‑resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin‑1
2019
·
Yingying Gao
, Luo Li
, et al.
·
International Journal of Oncology
·
33
Multi-objective optimization scheduling for manufacturing process based on virtual workflow models
2022
·
Zhen Quan
, Yan Wang
, et al.
·
Applied Soft Computing
·
30
Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway
2017
·
Min Tang
, Yan Zhao
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
30
HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro
2018
·
Zhongbo Du
, Luo Li
, et al.
·
International Journal of Oncology
·
26
PDF
Lycopene enhances the sensitivity of castration-resistant prostate cancer to enzalutamide through the AKT/EZH2/ androgen receptor signaling pathway
2022
·
Xiong Chen
, Guo Yang
, et al.
·
Biochemical and Biophysical Research Communications
·
25
5-Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene
2015
·
XIAORONG WANG
, E. CHEN
, et al.
·
Oncology Reports
·
22
PDF
MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase Cε and correlated with poor prognosis in prostate cancer
2021
·
Jiayu Liu
, Zhen Quan
, et al.
·
Biochemical and Biophysical Research Communications
·
20
Combination of phospholipase Cε knockdown with GANT61 sensitizes castration‑resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway
2019
·
Wei Sun
, Luo Li
, et al.
·
Oncology Reports
·
19
PDF
Nuclear factor-κB signaling pathway is involved in phospholipase Cε-regulated proliferation in human renal cell carcinoma cells
2014
·
Hong-fei Du
, Li-ping Ou
, et al.
·
Molecular and Cellular Biochemistry
·
15
HepaCAM inhibits clear cell renal carcinoma 786-0 cell proliferation via blocking PKCε translocation from cytoplasm to plasma membrane
2014
·
Bing Tan
, Jinxiang Tan
, et al.
·
Molecular and Cellular Biochemistry
·
14
PLCɛ maintains the functionality of AR signaling in prostate cancer via an autophagy-dependent mechanism
2020
·
Zhen Quan
, Ting Li
, et al.
·
Cell Death and Disease
·
10
PDF
Ionizing Radiation Combined with PARP1 Inhibitor Reduces Radioresistance in Prostate Cancer with RB1/TP53 Loss
2021
·
Yao Fan
, Hui Fan
, et al.
·
Cancer Investigation
·
9
Phospholipase C (PLC)ε Promotes Androgen Receptor Antagonist Resistance via the Bone Morphogenetic Protein (BMP)-6/SMAD Axis in a Castration-Resistant Prostate Cancer Cell Line
2019
·
Mengjuan Yuan
, Yingying Gao
, et al.
·
Medical Science Monitor
·
8
PDF
The targeted inhibition of prostate cancer by iron-based nanoparticles based on bioinformatics
2020
·
Feng Xiao
, Jiayu Liu
, et al.
·
Journal of Biomaterials Applications
·
7
PDF
PLCε knockdown enhances the radiosensitivity of castration‑resistant prostate cancer via the AR/PARP1/DNA‑PKcs axis
2020
·
Jun Pu
, Ting Li
, et al.
·
Oncology Reports
·
7
PDF
Predictive model for persistent hypertension after surgical intervention of primary aldosteronism
2023
·
Zhuoying Li
, Yunfeng He
, et al.
·
Scientific Reports
·
5
PDF
RETRACTED: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCε/PKCε Signaling Pathway
2020
·
Jiayu Liu
, Yongbo Zheng
, et al.
·
Frontiers in Oncology
·
5
PDF
HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain
2019
·
Qingfu Deng
, Li Luo
, et al.
·
Molecular Medicine Reports
·
5
PDF
[Corrigendum] PLCε knockdown enhances the radiosensitivity of castration‑resistant prostate cancer via the AR/PARP1/DNA‑PKcs axis
2022
·
Jun Pu
, Ting Li
, et al.
·
Oncology Reports
·
1
[Expression of Concern] 5‑Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene
2026
·
Xiaorong Wang
, E. Chen
, et al.
·
Oncology Reports
PDF
[Corrigendum] Combination of phospholipase Cε knockdown with GANT61 sensitizes castration‑resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway
2022
·
Wei Sun
, Luo Li
, et al.
·
Oncology Reports
PDF
Show more works
View as search
Works count:
27
Citation count:
513
H-index:
14
I10-index:
15
Year
Topic
Type